Research plays a pivotal role in comprehending multiple sclerosis mechanisms and discovering novel therapeutics. Each year, around 50 clinical and laboratory studies are executed within our research unit. This provides participants the access to innovative treatments yet not included in Israel's approved drug list. We stringently adhere to the regulations set by the Israeli Ministry of Health, the Helsinki Committee, and the management of the Multiple Sclerosis Center, ensuring that all clinical studies are conducted with utmost care and integrity.